Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | OKN4395 |
| Trade Name | |
| Synonyms | OKN-4395|OKN 4395 |
| Drug Descriptions |
Limited information is currently available on OKN4395, a putative EP2 and EP4 inhibitor (Jan 2025). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Famotidine + OKN4395 | Famotidine OKN4395 | 0 | 1 |
| OKN4395 | OKN4395 | 0 | 1 |
| OKN4395 + Pembrolizumab | OKN4395 Pembrolizumab | 0 | 1 |